Neurocrine Biosciences
NBIX
#1290
Rank
C$19.69 B
Marketcap
$194.57
Share price
0.34%
Change (1 day)
20.89%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Neurocrine Biosciences (NBIX) - Total assets

Total assets on the balance sheet as of September 2024 : C$5.07 Billion

According to Neurocrine Biosciences 's latest financial reports the company's total assets are C$5.07 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Neurocrine Biosciences - Total assets on balance sheet (from 2001 to 2024)

Total assets by year

Year Total assets Change
2023-12-31C$4.31 B34.17%
2022-12-31C$3.21 B21.69%
2021-12-31C$2.64 B19.41%
2020-12-31C$2.21 B29.67%
2019-12-31C$1.70 B26.08%
2018-12-31C$1.35 B31.61%
2017-12-31C$1.02 B109.51%
2016-12-31C$0.49 B-25.51%
2015-12-31C$0.65 B133.52%
2014-12-31C$0.28 B71.29%
2013-12-31C$0.16 B-15.51%
2012-12-31C$0.19 B38.46%
2011-12-31C$0.14 B-2.51%
2010-12-31C$0.14 B93.74%
2009-12-31C$74.51 M-48.14%
2008-12-31C$0.14 B-47.93%
2007-12-31C$0.27 B-39.17%
2006-12-31C$0.45 B-19.34%
2005-12-31C$0.56 B-9.81%
2004-12-31C$0.62 B-13.37%
2003-12-31C$0.71 B71.01%
2002-12-31C$0.42 B-23.7%
2001-12-31C$0.55 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
C$4.06 B-19.93%๐Ÿ‡บ๐Ÿ‡ธ USA
C$25.92 B 410.39%๐Ÿ‡ฌ๐Ÿ‡ง UK
C$4.9 M-99.90%๐Ÿ‡บ๐Ÿ‡ธ USA
C$108.63 B 2,038.81%๐Ÿ‡บ๐Ÿ‡ธ USA
C$206.06 B 3,957.20%๐Ÿ‡บ๐Ÿ‡ธ USA
C$315.34 B 6,108.66%๐Ÿ‡บ๐Ÿ‡ธ USA
C$1.84 B-63.58%๐Ÿ‡บ๐Ÿ‡ธ USA
C$10.67 M-99.79%๐Ÿ‡บ๐Ÿ‡ธ USA